If you could vote on Brexit now which option would you choose?
   

Gilead recalls 2 lots of COVID-19 drug Veklury after finding glass particulates in vials


Gilead Sciences' surprise blockbuster Veklury has braved its share of efficacy critiques. Now, the drug has run up against a manufacturing glitch. Gilead is recalling two lots of the COVID-19 antiviral Veklury, also known as remdesivir, after a customer complaint flagged the presence of glass particulates. Gilead confirmed the complaint through its own investigation, the company said Friday. Veklury was among the vanguard of COVID-19 treatments last year. It remains the first and only coronavirus med to snag a full FDA approval. Despite questions about its efficacy, the antiviral has enjoyed a resurgence in the second half of 2021 thanks to the spread of virus variants and elevated hospitalization rates.

FiercePharma - December 6, 2021

View the full story here: https://www.fiercepharma.com/manufacturing/gilead-recalls-two-lots-covid-19-drug-veklury-after-investigation-confirms-glass